{"result": "(\"entity\"<|>ANN OTOl RHINOL LARYNGOL<|>ORGANIZATION<|>Ann Otol Rhinol Laryngol is a medical journal that publishes research related to otolaryngology, including studies on oropharyngeal dysphagia.)\n##\n(\"entity\"<|>NAT REV GASTROENTEROL HEPATOL<|>ORGANIZATION<|>Nat Rev Gastroenterol Hepatol is a journal that focuses on gastroenterology and hepatology, providing reviews and research articles on various topics including dysphagia.)\n##\n(\"entity\"<|>AJR AM J ROENTGENOL<|>ORGANIZATION<|>AJR Am J Roentgenol is a journal that publishes articles on radiology, including studies on the fluoroscopic evaluation of oropharyngeal dysphagia.)\n##\n(\"entity\"<|>SUPPORT CARE CANCER<|>ORGANIZATION<|>Support Care Cancer is a journal that publishes research on supportive care in cancer patients, including nutritional therapy studies.)\n##\n(\"entity\"<|>EUR J CLIN NUTR<|>ORGANIZATION<|>Eur J Clin Nutr is a journal that publishes clinical nutrition research, including studies on enteral nutrition in cancer patients.)\n##\n(\"entity\"<|>NUTRI-JELLY<|>EVENT<|>Nutri-jelly is a nutritional product that may improve quality of life and decrease tube feeding demand in head and neck cancer patients.)\n##\n(\"entity\"<|>L-GLUTAMINE<|>EVENT<|>L-glutamine is a supplement studied for its effects on mucositis severity in patients undergoing chemoradiotherapy for head and neck cancer.)\n##\n(\"entity\"<|>ESPEN GUIDELINES<|>EVENT<|>ESPEN Guidelines provide recommendations for enteral nutrition in various clinical settings, including surgery and organ transplantation.)\n##\n(\"entity\"<|>DE LUIS DA<|>PERSON<|>DA de Luis is a researcher involved in multiple studies related to enteral nutrition and its effects on cancer patients.)\n##\n(\"relationship\"<|>DE LUIS DA<|>ANN OTOl RHINOL LARYNGOL<|>DA de Luis has contributed research published in Ann Otol Rhinol Laryngol regarding dysphagia<|>7)\n##\n(\"relationship\"<|>DE LUIS DA<|>NAT REV GASTROENTEROL HEPATOL<|>DA de Luis has contributed research published in Nat Rev Gastroenterol Hepatol on dysphagia<|>7)\n##\n(\"relationship\"<|>DE LUIS DA<|>AJR AM J ROENTGENOL<|>DA de Luis has contributed research published in AJR Am J Roentgenol regarding fluoroscopic evaluation of dysphagia<|>7)\n##\n(\"relationship\"<|>DE LUIS DA<|>SUPPORT CARE CANCER<|>DA de Luis has contributed research published in Support Care Cancer on nutritional therapy for cancer patients<|>7)\n##\n(\"relationship\"<|>DE LUIS DA<|>EUR J CLIN NUTR<|>DA de Luis has contributed research published in Eur J Clin Nutr on enteral nutrition in cancer patients<|>7)\n##\n(\"relationship\"<|>NUTRI-JELLY<|>SUPPORT CARE CANCER<|>Nutri-jelly is discussed in Support Care Cancer for its potential benefits in head and neck cancer patients<|>5)\n##\n(\"relationship\"<|>L-GLUTAMINE<|>AJR AM J ROENTGENOL<|>L-glutamine is studied in AJR Am J Roentgenol for its effects on mucositis in head and neck cancer patients<|>5)\n##\n(\"relationship\"<|>ESPEN GUIDELINES<|>EUR J CLIN NUTR<|>ESPEN Guidelines are referenced in Eur J Clin Nutr for recommendations on enteral nutrition<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: EAT-10). Ann Otol Rhinol Laryngol. 2008 Dec; 117(12):919-24.\n\n14. Rommel N, Hamdy S. Oropharyngeal dysphagia: manifestations and diagnosis. Nat Rev Gastroenterol Hepatol. 2016 Jan; 13(1):49-59.\n\n15. Jaffer NM, Ng E, Au FW, Steele CM. Fluoroscopic evaluation of oropharyngeal dysphagia: anatomic, technical, and common etiologic factors. AJR Am J Roentgenol. 2015 Jan; 204(1):49-58.\n\n16. Senft M, Fietkau R, Iro H, Sailer D, Sauer R. The influence of supportive nutritional therapy via percutaneous endoscopically guided gastrostomy on the quality of life of cancer patients. Support Care cancer 1993; 1:272-275.\n\n17. Clavé P, Shaker R. Dysphagia: current reality and scope of the problem. Nat Rev Gastroenterol Hepatol. 2015 May; 12(5):259-70.\n\n18. DA de Luis, O Izaola, R Aller, L Cuellar, MC Terroba. Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical. Eur J Clin Nutr 2004; 58:1505-1508.\n\n19. DA de Luis, O izaola, R Aller, L Cuellar, MC Terroba. Postsurgery enteral immunonutrition in head and neck cancer patients. Eur J Clin Nutr 2002. 56, 1126-1129.\n\n20. DA de Luis, O Izaola, L Cuellar, MC Terroba, T Martin, R Aller. Clinical and biochemical outcomes after a randomized trial with a high dose of enteral arginine formula in postsurgical head and neck cancer patients. E J Clin Nutr 2006; 1-5.\n\n21. DA de Luis, O izaola, R Aller, L Cuellar, MC Terroba. Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patients Eur J Clin Nutr 2005; 59:145-147.\n\n22. DA de Luis, O Izaola, R Aller, L Cuellar, MC Terroba. Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical. Eur J Clin Nutr 2004; 58:1505-1508.\n\n23. de Luis DA, Izaola O, Aller R, Cuellar L, Terroba MC, Martin M. A randomized clinical trial with two omega 3 fatty acid enhanced oral supplements in ehad and neck cancer ambulatory patients. Eurpean Rev for Med and Pharmacol Sci 2008; 12:177-181.\n\n24. de Luis DA1, Izaola O, Cuellar L, Terroba MC, de la Fuente B, Cabezas G A randomized clinical trial with two doses of a omega 3 fatty acids oral and arginine enhanced formula in clinical and biochemical parameters of head and neck cancer ambulatory patients. Eur Rev Med Pharmacol Sci. 2013 Apr; 17(8):1090-4.\n\n25. Trachootham D1, Songkaew W, Hongsachum B, Wattana C, Changkluengdee N, Karapoch J, Thirdsuttironnapumi S, Meennuch E, Klaitong C, Sinthusek T,Lam-ubol A. Nutri-jelly may improve quality of life and decrease tube feeding demand in head and neck cancer patients. Support Care Cancer. 2015 May; 23(5):1421-30.\n\n26. Tsujimoto T, Yamamoto Y, Wasa M, Takenaka Y, Nakahara S, Takagi T, Tsugane M, Hayashi N, Maeda K, Inohara H, Uejima E, Ito T. L-glutamine decreases the severity of mucositis induced by chemoradiotherapy in patients with locally advanced head and neck cancer: a double-blind, randomized, placebo-controlled trial. Oncol Rep. 2015 Jan; 33(1):33-9.\n\n27. de Luis DA, Gonzalez sagrado M, Vallejo LA, Gil Carcedo JM, Izaola O, Cuellar L. Influence of G308A polymorphism of tumor necrosis factor alfa gene on inflammatory markers in postsurgical head and neck cancer patients with early enteral nutrition. Nutrition 2007; 23:529-532.\n\n28. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN 2002; 26 (Supp).\n\n29. Valentini L, Schütz T, Allison S, Howard P, Pichard C, Lochs H. ESPEN Guidelines on enteral nutrition. Clin Nutr. 2006; 25:260-74.\n\n30. Weimann A, Braga M, HArsanyi L, Laviano A, Ljungqvist O, Soeters P. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clinical Nutrition 2006; 26:224-244.\n\n31. De Luis DA1, Izaola O, Terroba MC, Cuellar L, Ventosa M, Martin T Effect of three different doses of arginine enhanced enteral nutrition on nutritional\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}